Mounjaro
(Tirzepatide)
Dual-Action Support. Advanced Results.
The First FDA-Approved GIP and GLP-1 Receptor Agonist
Our Mounjaro (Tirzepatide) Injection represents the next generation of metabolic health treatments. Unlike traditional GLP-1s, Mounjaro is a dual-acting medication that targets two separate hormone receptors—GIP and GLP-1—to regulate blood sugar and curb appetite more effectively. By slowing digestion and sending signals of fullness to the brain, this once-weekly treatment helps you manage your health with clinical precision.
Active Ingredient
Tirzepatide
Administration
Self-administered once weekly via a discreet, easy-to-use injection pen.
Dosages
Available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg single-dose pre-filled pens.
Proven Efficacy
Clinical studies show Mounjaro provides superior A1C reduction and significant weight management compared to single-hormone treatments.
Dual-Action
The only treatment that activates both GIP and GLP-1 pathways for enhanced metabolic support
Discreet
Ships directly to your door in refrigerated, temperature-controlled, neutral packaging.
How It Works



Create an account
Answer a few quick questions about your health. Don't worry, the information will be private and secure and will only be used by our physicians to evaluate and assess your treatment.
Receive your treatment plan
Our physicians shall confirm the recommended treatment after just a few moments, and your order will then be finalized.
Get your medication
We shall promptly ship your treatment medication to your address.
Your Privacy is Our Priority
Every Aria Health Rx order arrives in an unmarked mailing box
There are no mentions of any medication or Aria Health on the exterior
Your privacy is preserved from the moment it leaves our pharmacy to the moment it reaches your door

